Market

Difficult Intubations

  • Major adverse consequences can occur if the airway not secured in a timely fashion.
  • The process itself remains complex.
  • Patients who are obese, combative, hypoxemic, or hypotensive, or who have pre-existing conditions create intubation challenges.
  • Outside the OR, intubation is rarely “routine.”

jama

Key findings, JAMA Study published 23 Mar 2021
Journal of the American Medical Association involving 2,964 critically ill men and women, requiring invasive procedures in 29 countries from 1 Oct 2018 to 31 July 2019

  • 45.2% of patients experienced at least one life-threatening complication followed intubation
  • 42.6% suffered severe cardiopulmonary instability
  • 272 patients, 9.3%, suffered severe hypoxemia/low oxygen levels
  • 93 patients, 3.1% suffered cardiac arrest
  • Patients at the highest risk of life-threatening complications had hemodynamic instability prior to intubation
  • Successful intubation on the first attempt was associated with a lower risk of complications compared to repeated attempts

 

Training

  • For optimal outcome: a complex intubation procedure currently requires an experienced Anesthesiologist with hours of training and many prior intubations.
  • Medical professionals other than Anesthesiologists also perform intubations: Emergency physicians and other physicians, nurse anesthetists, EMT personnel as well as medics on the battlefield.

COVID-19 and Other Viruses

Tens of thousands of intubations have been performed globally during the Covid-19 pandemic as well as during other past viral epidemics.

  • Intubations performed on deteriorating patients are difficult and dangerous.
  • The Anesthesiologist or Intensivist performing the intubation is at risk of being extremely close to the patient’s oral cavity during the procedure.

The LightSpeed Intubator™ (LSI) with Optical Stylet™ synergizes the disparate technologies comprising current standards of care into a single, integrated device. The LightSpeed Intubator™(LSI) and Optical Stylet™will make the intubation procedure safer, faster, and easier to perform.

We anticipate high acceptance rates in the US and global markets due to considerations of portability, rapid deployment, ease of use, and the volume of the Endotracheal Tube (ETT) market.

These products will be sold to hospital departments, ambulatory surgery centers (ASCs), and medical mobile emergency providers (military, government, and civilian). Stakeholders include physicians and medical personnel in Pulmonary, Emergency, Critical Care, Anesthesia and ENT, and nursing and technical staff. Other clinical interests will be Risk Management, Infection Control, Quality Assurance, and Nurse Administration. Business stakeholders will include Administrators, Value Analysis, New Product Committees, and Materials Management/Purchasing.

The Global Endotracheal Tube Market is Estimated to Reach USD 1.294 Billion by 2026

FDA Disclosure

FDA REGULATORY DISCLOSURE: Intubation Science, Inc. is an emerging technology company. These products are investigational medical devices that have not been approved or cleared for use in the United States.